Risperdal Side Effects Lawyers


 

If you or your child has taken Risperdal and have developed gynecomastia (abnormal breast growth), call today about your legal rights. Lawsuits have been filed against Johnson & Johnson Nationwide for their illegal marketing and advertising of Risperdal for pediatric use without having the proper FDA approval to do so.

Originally, Johnson & Johnson produced the drug Risperdal to treat adults with schizophrenia.  While never receiving FDA approval for use in children, Risperdal was used by children to treat various behavior disorders including ADD, autism, bi-polar disorder, schizophenia and aggression among others.

The use of Risperdal was never approved for pediatric use, and Johnson & Johnson was illegally promoting its use prior to receiving any such approval.  The side effects of Risperdal in boys and young men can be very serious; including gynecomastia – abnormal breast growth in men.

$2.2 Billion Settlement for Risperdal Announced by Johnson & Johnson

In November 2013, the Justice Department and Johnson & Johnson announced a settlement of more than $2.2 billion in criminal and civil penalties related to its drug Risperdal.  It has been alleged that J&J improperly marketed the antipsychotic drug.

This settlement is not only one of the largest pharmaceutical settlements in history but marks the changed landscaped in drug companies who illegal market drugs to obtain a larger share of the market.

Risperdal has been on the market since 1999 and is one of J&J’s most popular drugs and generated over $3 billion is sales in 2004. The approval from the FDA to market Risperdal was not obtained until 2006.

What is Risperdal?

Risperidone (Risperdal) is an antipsychotic drug used to treat various behavior disorders, schizophrenia, autism, dementia and bipolar disorder.

Developed by Johnson & Johnson and marketed though its Jensen division in 1999.

What is the Risperdal Lawsuit About?

Lawsuits have been filed on behalf of patients who have taken Risperdal (also known as risperidone, Invega, or paliperidone) and have developed gynecomastia (female-like breasts) in boys and young men.

The marketing of Risperdal to children was never approved by the FDA and the off-label use was considered illegal by the Justice Department.

Risperdal increases the levels of prolactin which stimulates breast growth.  Boys and young men who have developed gynecomastia may experience pain or nipple discharge.